ANG Lifesciences India Ltd Financial Ratios
ANG · Healthcare · Current price ₹33.3
P/E ratio
—
P/B ratio
0.8x
ROE
-19.4%
ROCE
-4.0%
Debt / Equity
1.49
Dividend yield
3.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | — | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 0.8x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -19.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -4.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 1.49 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with ANG Lifesciences India Ltd's latest numbers.
ANG Lifesciences India Ltd profitability
ANG Lifesciences India Ltd generates a return on equity of -19.4% and a return on capital employed of -4.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 1.49 and a P/E of —, ANG Lifesciences India Ltd is moderately leveraged. Our overall business-quality score for the company is 2.7 / 10.
Understand the ratios
More on ANG Lifesciences India Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.